GE HealthCare Technologies Inc. reaffirmed earnings guidance for the full year 2024. For the year, the company expected organic revenue growth of approximately 4% year-over-year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
81.94 USD | +0.23% | +1.76% | +5.98% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.98% | 37.4B | |
+11.18% | 225B | |
+15.22% | 197B | |
+19.19% | 143B | |
+30.89% | 111B | |
+2.55% | 64.72B | |
+18.48% | 54.44B | |
+5.12% | 51.06B | |
+10.53% | 45.03B | |
+26.89% | 32.07B |
- Stock Market
- Equities
- GEHC Stock
- News GE HealthCare Technologies Inc.
- GE HealthCare Technologies Inc. Reaffirms Earnings Guidance for the Full Year 2024